Lecture 9-Neuropsychiatric Medications Flashcards
Status epilepticus first phase = ___-___ minutes; ___ is treatment of choice
status epilepticus first phase = 5-20 minutes; benzo is treatment of choice (i.e.: versed, Ativan, valium)
Status epilepticus second phase = ___-___ minutes; there ___ (is/is no) evidence based first choice; may use ___, ___, or ___
status epilepticus second phase = 20-40 minutes; there is no evidence based first choice; may use fosphenytoin, valproic acid, or keppra
Status epilepticus third phase = ___-___ minutes; can repeat any ___ (first/second) line therapy; ___ doses of thiopental, midazolam, pentobarbital, or propofol
status epilepticus third phase = 40-60 minutes; can repeat any second line therapy; anesthetic doses of thiopental, midazolam, pentobarbital, or propofol
Anticonvulsant medications are only approved to treat seizures–T/F?
False–there are several approved/unapproved indications
i.e.: neuropathic pain, mood stabilization, migraines, alcohol dependence
Anticonvulsants MOA–___ channel blockade, ___ channel blockade
sodium channel blockade, calcium channel blockade
Anticonvulsants calcium channel blockade–particularly the ___-type channels located in the ___ which act as ‘pacemakers’ of normal rhythmic brain function
Anticonvulsants calcium channel blockade–particularly the T-type channels located in the thalamus which act as ‘pacemakers’ of normal rhythmic brain function
Anticonvulsants other MOAs–GABA ___ (enhancers/inhibitors); glutamate ___ (enhancers/blockers); carbonic anhydrase ___ (enhancers/inhibitors); ___ hormones; synaptic vesicle protein ___
GABA enhancers [remember GABA is inhibitory]; glutamate blockers [remember glutamate is excitatory]; carbonic anhydrase inhibitors; sex hormones; synaptic vesicle protein 2A (SV2A)
Anticonvulsant medications–carbamazepine, oxcarbazepine, eslicarbazepine, phenytoin/fosphenytoin, lamotrigine, zonisamide, lacosamide, and cenobamate are all ___ channel blockers
all sodium channel blockers
Carbamazepine multiple uses–___ and ___ seizures; mood ___; ___ pain; ___ neuralgia
partial and generalized seizures; mood stabilizer; neuropathic pain; trigeminal neuralgia
Carbamazepine ___ (induces/inhibits) its own metabolism
Carbamazepine induces its own metabolism
Carbamazepine is a CYP3A4 ___ (inducer/inhibitor)
Carbamazepine is a CYP3A4 inducer
What is the most important thing to consider about carbamazepine?
Drug interactions–because it is a CYP inducer/substrate, it ramps up the metabolism of other drugs and itself, clears medications from the bloodstream faster, and shortens the duration of action of other drugs
Carbamazepine side effects–___ea, ___ syndrome, ___ (increased/decreased) LFTs, ___natremia
nausea, Stevens-Johnson syndrome, increased LFTs, hyponatremia
If patient is on carbamazepine, check ___ levels
sodium levels
Why was oxcarbazepine created?–to eliminate the auto-___ of carbamazepine
to eliminate the auto-induction of carbamazepine
As a person takes carbamazepine for a longer period of time, it loses its effectiveness because it’s an inducer and substrate–T/F?
True
Eslicarbazepine is a ___drug
prodrug –> S-licarbazepine
If patient has renal impairment, you need to adjust the dose of eslicarbazepine–T/F?
True
Main concerns for the -carbazepine anticonvulsants–check ___ levels, check for drug ___, check ___/___s
check sodium levels, check for drug interactions, check CBC/LFTs
Most common side effects with eslicarbazepine (> 10%)–___ness, ___lence, ___ea, ___ache, ___opia
dizziness, somnolence, nausea, headache, diplopia
Phenytoin is a ___ channel blocker; has ___ (linear/non-linear) pharmacokinetics; CYP enzyme ___ and ___
Phenytoin is a sodium channel blocker; has non-linear pharmacokinetics; CYP inducer and substrate
What is the therapeutic range for phenytoin?
10-20
Dose adjustments for phenytoin are ___ (small/large)
Small because it has non-linear pharmacokinetics
Example: Patient is on 300 mg phenytoin. You check a level and it comes back at 5. You increase the dose to 300 mg bid. You re-check the level and it is 28, and patient is dizzy, nauseous, and having vision changes. You may just add 30-50 mg at a time to get to desired therapeutic levels for phenytoin.
Fosphenytoin = ___drug for ___ (oral/parenteral) administration
prodrug for parenteral administration